Back to RecallTracker
Health Canada Medical devices

Beckman Coulter Access Erythropoetin Reagent

Issued April 9, 2025
Issue
Beckman Coulter has determined that the affected access erythropoietin (EPO) reagent lot number exhibits an approximate concentration bias of ~-22% with patient samples when compared to alternate EPO reagent lots. Recall start date: February 3, 2025
Hazard description
Performance
Product
Product name
Beckman Coulter Access Erythropoetin Reagent
Reference
ID
RA-77250